Aspen Aerogels
Aspen Aerogels' revenue fell 40.1% to $271 million in fiscal 2025. Its operating margin was −139.5%, down from 12.1% a year earlier. Free cash flow was −$5 million. The diluted share count rose 2.5%.
Operating margin is operating income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on capital is after-tax operating income as a share of the money invested in the business: debt plus equity, minus cash. Market cap is the last closing share price times the latest diluted share count, so it is approximate. P/E is the last close divided by diluted earnings per share over the last four quarters, or the latest fiscal year where the quarters aren't available; there is none when the company made a loss.
Charts show fiscal years, from the 10-K filings.
What Aspen Aerogels does
Aspen Aerogels makes aerogel, a very light insulating material. It sells two main kinds of products: thermal barriers that sit between battery cells in electric vehicles and energy storage systems to slow the spread of a battery fire, and insulation blankets for refineries, chemical plants, liquefied natural gas facilities and power plants.
The electric vehicle market and the energy industrial insulation market are its two principal markets. It has production contracts with General Motors, which can end them at any time, and with Toyota, Scania, Audi, Volvo Truck and others. General Motors was 59% of total revenue in 2025. Its insulation is sold through distributors, contractors and manufacturers of equipment. It says its products cost more than traditional insulation.
Aspen Aerogels competes with makers of other aerogel products, such as Armacell and Alkegen, and with traditional insulation makers. It had 854 full-time employees at the end of 2025.
Its biggest risks, as it describes them
- Depending on General Motors for most of its revenue, with a contract General Motors can end at any time.
- Its electric vehicle business depends on carmakers' plans and on consumers buying electric vehicles.
- Relying on outside factories in China to supply part of its aerogel.
- Needing more money for growth and keeping to the terms of its credit agreement.
- Competition from other aerogel and traditional insulation makers, and high prices for its products.
Income statement
Aspen Aerogels lost money in fiscal 2025: a net loss of $390 million.
Returns on capital
Balance sheet
Five years at a glance
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | 77 | 281 | 140 | 221 | 157 |
| Debt incl. finance leases | — | 104 | 115 | 95 | 70 |
| Net debt (negative means net cash) | — | −178 | −25 | −126 | −86 |
| Net debt to EBITDA | — | — | — | −1.6x | — |
| Debt to equity | — | 0.2x | 0.2x | 0.1x | 0.3x |
| Interest coverage | −172.0x | −517.9x | −49,203.0x | 7.8x | −30.9x |
| Current ratio | 3.1x | 4.7x | 3.4x | 3.7x | 3.9x |
| Quick ratio | 2.7x | 4.4x | 2.9x | 3.3x | 3.3x |
Cash flow
Projections
Project Aspen Aerogels' revenue, net income and earnings per share five years ahead in a bull, a base and a bear case with your own figures, and see the share prices your P/E estimates give them, or value it with a discounted cash flow model. Every projected figure is yours: it is not a forecast of ours.
What Aspen Aerogels says to expect
- Fourth quarter 2026: revenue
Q4 2026 Revenue is expected to range between $60 million and $75 million
- Fourth quarter 2026: net loss
Q4 2026 Net loss is expected to range between $11 million and $8 million
- Fourth quarter 2026: adjusted EBITDA
Q4 2026 Adjusted EBITDA is expected to range between $5 million and $13 million, which excludes an estimated $5 million to $10 million of East Providence incident-related costs, including expedited freight and expedited repair costs, professional fees, and the incremental cost of temporarily sourcing certain products from the Company's external manufacturing facility until the East Providence facility returns to full production capacity; the Company is engaged in the claims process under its insurance policies with respect to these costs
- Full year 2026: capital expenditures
FY 2026 Capital Expenditures, excluding costs related to the restoration of the East Providence facility, are expected to be less than $10 million
Insider trades
Over the 12 months between November 14, 2025 and November 13, 2026, no insider bought Aspen Aerogels shares on the open market, and 1 insider sold $58.1 million.
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 23, 2026 | Wood River Capital LLCFormer 10% Owner | Sold | 12,280,426 | $4.73 | $58.1 million | Form 4 |
Indicators
Four widely used measures, worked out from the company's filings. The cutoffs are the ones their authors or users go by, not a verdict of ours.
| Indicator | FY23 | FY24 | FY25 |
|---|---|---|---|
| Piotroski F-score | 4 of 9 | 8 of 9 | 4 of 9 |
| Rule of 40 | −59.0% | 80.6% | −41.8% |
| Altman Z'' | 0.55 | 2.50 | −10.32 |
| Accruals ratio | −0.5% | −4.0% | −64.9% |
The nine F-score tests
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | Fail | Pass | Fail |
| Cash from operations is positive | Fail | Pass | Pass |
| Return on assets rose | Pass | Pass | Fail |
| Cash from operations exceeds net income | Pass | Pass | Pass |
| Debt fell relative to assets | Pass | Pass | Pass |
| Current ratio rose | Fail | Pass | Pass |
| Share count didn't rise | Fail | Fail | Fail |
| Gross margin rose | Pass | Pass | Fail |
| Revenue rose relative to assets | Fail | Pass | Fail |
| F-score | 4 of 9 | 8 of 9 | 4 of 9 |
Compare
Put Aspen Aerogels side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.
Similar companies
| Company | Year | Revenue growth | Operating margin | Free cash flow margin | Return on capital | Net debt to EBITDA | F-score | Compare |
|---|---|---|---|---|---|---|---|---|
| Aspen Aerogels | FY25 | −40.1% | −139.5% | −1.7% | −93.7% | — | 4 | |
| Core Molding Technologies | FY25 | −9.4% | 5.2% | 0.7% | 8.2% | −0.8x | 6 | Compare |
| Perimeter Solutions | FY25 | 16.4% | −30.8% | 31.9% | −10.2% | — | 5 | Compare |
| Ecovyst | FY25 | 20.9% | 9.0% | 9.7% | 2.9% | 1.4x | 6 | Compare |
| Alto Ingredients | FY25 | −4.9% | 0.8% | 0.9% | 2.5% | 1.9x | 6 | Compare |
10 years of figures
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | 118 | 112 | 104 | 139 | 100 | 122 | 180 | 239 | 453 | 271 |
| Revenue growth | −3.9% | −5.2% | −6.5% | 33.5% | −28.1% | 21.3% | 48.3% | 32.4% | 89.6% | −40.1% |
| Gross profit | 23 | 19 | 13 | 26 | 15 | 10 | 5 | 57 | 183 | 46 |
| Research and development | 5 | 6 | 6 | 8 | 9 | 11 | 17 | 16 | 18 | 13 |
| Operating income | −11 | −19 | −34 | −14 | −22 | −41 | −79 | −49 | 54 | −378 |
| Net income | −12 | −19 | −34 | −15 | −22 | −37 | −83 | −46 | 13 | −390 |
| Diluted EPS (US$) | −0.52 | −0.83 | −1.45 | −0.60 | −0.83 | −1.22 | −2.10 | −0.66 | 0.17 | −4.73 |
| Diluted shares (millions) | 23 | 23 | 24 | 24 | 26 | 30 | 39 | 69 | 80 | 82 |
| Cash flow | ||||||||||
| Cash from operations | −1 | −5 | −9 | −1 | −10 | −19 | −94 | −43 | 46 | 33 |
| Capital expenditure | 13 | 6 | 4 | 2 | 3 | 14 | 178 | 176 | 86 | 37 |
| Free cash flow | −14 | −11 | −12 | −3 | −13 | −32 | −272 | −218 | −41 | −5 |
| Dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share buybacks | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock-based compensation | 5 | 5 | 4 | 4 | 5 | 5 | 9 | 11 | 13 | 9 |
| Balance sheet at fiscal year end | ||||||||||
| Cash and short-term investments | 18 | 11 | 3 | 4 | 16 | 77 | 281 | 140 | 221 | 157 |
| Debt incl. finance leases | — | — | — | — | 4 | — | 104 | 115 | 95 | 70 |
| Total assets | 135 | 124 | 99 | 104 | 97 | 183 | 643 | 703 | 895 | 407 |
| Total liabilities | 19 | 23 | 29 | 44 | 30 | 54 | 196 | 215 | 280 | 171 |
| Shareholders' equity | 116 | 101 | 70 | 59 | 68 | 128 | 447 | 488 | 615 | 236 |
| Margins and ratios | ||||||||||
| Gross margin | 19.8% | 16.7% | 12.1% | 18.9% | 14.6% | 8.2% | 2.8% | 23.8% | 40.4% | 17.0% |
| Operating margin | −9.5% | −17.1% | −32.5% | −10.2% | −21.5% | −33.4% | −43.9% | −20.6% | 12.1% | −139.5% |
| Net margin | −10.2% | −17.3% | −33.0% | −10.4% | −21.8% | −30.5% | −45.9% | −19.2% | 3.0% | −143.7% |
| Free cash flow margin | −11.7% | −9.6% | −11.7% | −2.3% | −13.3% | −26.6% | −151.0% | −91.3% | −9.0% | −1.7% |
| Rule of 40 (growth + FCF margin) | −15.6% | −14.8% | −18.2% | 31.3% | −41.4% | −5.3% | −102.7% | −59.0% | 80.6% | −41.8% |
| Return on capital | — | — | — | — | — | — | — | −10.6% | 10.2% | −93.7% |
| Return on equity | −10.1% | −17.9% | −40.2% | −22.5% | −34.4% | −37.8% | −28.7% | −9.8% | 2.4% | −91.6% |
| Return on assets | −8.8% | −14.9% | −30.9% | −14.4% | −21.7% | −26.5% | −20.0% | −6.8% | 1.7% | −59.9% |
| Net debt to EBITDA | — | — | — | — | — | — | — | — | −1.6x | — |